I disagree with the assessment that it was a strong quarter. quarter over quarter rev growth was laughable. They offered no insight as to when the bleeding would stop. 12 months cash left when sales are still anemic and no guidance are why we are selling off, not news of a fake potential competitor.
Yeah heard the response about blfs also, there are lots of 'drive bye' posts on stocktwits bashing cryoport claiming blfs is superior in financials, clients and tech.
We know cyrx tech is superior, so my thought is there is a concerted effort to slow client adoption of cyrx, or worse scam clients away from cyrx.
I hate to continue saying long term, but another few quarters we wait I guess.
News 
Market Data 
Discover 
